Holen Sie sich die Stockscreener-App
1.77
5.99%
0.10
Handel nachbörslich:
1.73
-0.04
-2.26%
Schlusskurs vom Vortag:
$1.67
Offen:
$1.74
24-Stunden-Volumen:
265.83K
Relative Volume:
0.49
Marktkapitalisierung:
$92.60M
Einnahmen:
$21.05M
Nettoeinkommen (Verlust:
$-89.22M
KGV:
-0.9888
EPS:
-1.79
Netto-Cashflow:
$-64.50M
1W Leistung:
+2.31%
1M Leistung:
-2.21%
6M Leistung:
-13.24%
1J Leistung:
-69.80%
1-Tages-Spanne:
$1.6801
$1.7872
1-Wochen-Bereich:
$1.60
$1.7872
52-Wochen-Spanne:
$1.02
$6.225
Tscan Therapeutics Inc Stock (TCRX) Company Profile
Firmenname
Tscan Therapeutics Inc
Sektor
Branche
Telefon
857-399-9500
Adresse
880 WINTER STREET, WALTHAM
Vergleichen Sie TCRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TCRX
Tscan Therapeutics Inc
|
1.77 | 94.51M | 21.05M | -89.22M | -64.50M | -1.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Tscan Therapeutics Inc Stock (TCRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-05-16 | Eingeleitet | BTIG Research | Buy |
| 2024-05-13 | Eingeleitet | Needham | Buy |
| 2023-06-22 | Eingeleitet | Wedbush | Outperform |
Tscan Therapeutics Inc Aktie (TCRX) Neueste Nachrichten
TScan Therapeutics’s SWOT analysis: biotech stock faces pivotal year By Investing.com - Investing.com Australia
TScan Therapeutics Inc. recovery potential after sell offExit Point & Weekly High Return Opportunities - Newser
What moving averages say about TScan Therapeutics Inc.Portfolio Risk Summary & High Win Rate Trade Tips - Newser
Order flow analysis tools used on TScan Therapeutics Inc.July 2025 Setups & Verified Swing Trading Watchlists - Newser
Volatility clustering patterns for TScan Therapeutics Inc.2025 Key Highlights & High Accuracy Buy Signal Tips - Newser
Real time scanner hits for TScan Therapeutics Inc. explainedMarket Movement Recap & Daily Profit Focused Stock Screening - Newser
Combining machine learning predictions for TScan Therapeutics Inc.July 2025 Gainers & Comprehensive Market Scan Reports - Newser
Visualizing TScan Therapeutics Inc. stock with heatmaps2025 Institutional Moves & AI Powered Buy and Sell Recommendations - Newser
Detecting price anomalies in TScan Therapeutics Inc. with AIDay Trading Setup Forecast with Trend Model - Newser
TScan Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire
TScan Therapeutics Reports Q2 2025 Financial Results - TipRanks
Identifying reversal signals in TScan Therapeutics Inc.Trade Risk Summary & Fast Moving Stock Watchlists - Newser
What recovery options are there for TScan Therapeutics Inc.Recession Risk & Weekly Chart Analysis and Guides - Newser
TScan Therapeutics 2025 Q2 Earnings Significant Revenue Growth Despite Deepening Net Loss - AInvest
What Fibonacci levels say about TScan Therapeutics Inc. reboundSmart Risk Entry Zone Technical Analysis - Newser
TScan Therapeutics Inc. Stock Support and Resistance Levels You Should KnowShort-Term Growth Watch with Signal Prediction - Newser
TScan Therapeutics, Inc. (TCRX) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
TScan Therapeutics shares rise 2.49% intraday after reporting positive second quarter 2025 results and upcoming trial data. - AInvest
Tscan Therapeutics earnings beat by $0.05, revenue topped estimates - Investing.com Canada
TScan Therapeutics, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2025 - MarketScreener
TScan Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
TScan Therapeutics: Pioneering TCR-T Therapies with Strong Pipeline Progress and Financial Resilience - AInvest
Should you hold or exit TScan Therapeutics Inc. nowFree Daily Picks With Predictable Performance - Newser
TScan Therapeutics Inc. stock trend forecastDaily Pick Forecast with Entry Zones - Newser
How high can TScan Therapeutics Inc. stock goQuick Profit Setup with Signal Forecast - Newser
Measuring TScan Therapeutics Inc.’s beta against major indicesTrade Ideas Based on Fundamental Metrics - Newser
Published on: 2025-08-09 20:27:19 - Newser
Custom strategy builders for tracking TScan Therapeutics Inc.Entry Point & Weekly High Potential Alerts - Newser
TScan Therapeutics (TCRX) Expected to Announce Quarterly Earnings on Monday - Defense World
TScan Therapeutics TCRX 2025Q2 Earnings Preview Downside Risk Amid Revenue Pressure - AInvest
How TScan Therapeutics Inc. stock performs during market volatilityCapital Growth Plan for New Investors - Newser
Real time alert setup for TScan Therapeutics Inc. performanceSwing Trade Signal and Price Prediction - Newser
Finanzdaten der Tscan Therapeutics Inc-Aktie (TCRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):